Dyne Therapeutics · 4 hours ago
Senior Director, Franchise Counsel
Waltham, MA
Full-time
Onsite
Director/Executive
$242K/yr - $291K/yr
10+ years expDyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The Franchise Counsel serves as the lead counsel for clinical therapies and pharmaceutical brands, providing legal guidance on commercialization issues as the company prepares for the launch of its first therapies.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Serve as lead counsel for Dyne’s therapeutic franchises, advising on commercial and medical strategies from development through launch
Provide legal review and counsel for promotional and non-promotional materials, including sales and marketing collateral, scientific exchange, digital media, and disease-state education
Advise on pricing, value & access strategies, contracting, trade and distribution matters, and patient access programs to ensure compliance with FDA, OIG, and industry standards
Support launch, inspection, and filing readiness activities across cross-functional teams
Advise on FDA regulations, federal and state fraud and abuse laws, and obligations under U.S. federal health care programs
Support the development, implementation, and monitoring of Dyne’s compliance program
Review and approve grants, sponsorships, and medical education programs in alignment with company policy and industry codes
Oversee transparency reporting, data privacy (including GDPR and U.S. state laws), and other global health care compliance obligations
Partner with Legal and Compliance colleagues to provide training and proactive risk assessments
Act as the primary legal business partner to key functions including Commercial, Medical Affairs, Regulatory, and G&A
Represent Legal on cross-functional project and governance teams to support launch readiness and commercial objectives
Collaborate with internal stakeholders and external partners to ensure compliant and effective business operations
Help mature Dyne’s health care law capabilities and identify opportunities for process improvement and proactive legal risk management
Support the Head of Legal in health care, compliance, and operational matters
Qualification
Required
JD from an accredited law school; licensed to practice in at least one U.S. jurisdiction
10+ years of health care law and compliance experience, ideally within a global biotechnology company and a top-tier law firm
Deep expertise in FDA regulations, U.S. health care laws, and federal health care programs; familiarity with ex-U.S. frameworks (e.g., EFPIA, GDPR)
Strong understanding of PhRMA Code, Anti-Kickback Statute, False Claims Act, data privacy, and transparency laws
Demonstrated content review committee experience in the pharmaceutical industry
Proven success advising cross-functional teams (Medical, Commercial, Regulatory, Technical Operations, and G&A) on complex, time-sensitive matters
Skilled at balancing strategic legal guidance with practical business judgment in fast-paced, evolving environments
Exceptional communication, analytical, and project management skills with attention to detail and execution excellence
Collaborative leadership style and enterprise mindset that reinforces organizational culture and values
Experience thriving in a small, rapidly growing biotech or start-up environment with a solutions-oriented approach
Company
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
51-200 employees
H1B Sponsorship
Dyne Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (7)
2023 (1)
2022 (3)
2021 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.67BKey Investors
Hercules CapitalAtlas Venture
2025-12-09Post Ipo Equity· $402.5M
2025-06-30Post Ipo Equity· $230M
2025-06-30Post Ipo Debt· $100M
Leadership Team
John Cox
Chief Executive Officer
Recent News
2025-12-24
MarketScreener
2025-12-24
2025-12-24
Company data provided by crunchbase